In a recent study, both KDM6B and islet1 (ISL1) expressions were reduced in NAFLD, and they synergistically inhibited adipogenesis while promoting lipolysis. The gene discussed is ISL1; the disease is metabolic dysfunction-associated steatotic liver disease.